Optimal Radiology taps McKesson for billing services

Lisa Fratt | | Health Imaging | Artificial Intelligence
Optimal Radiology in Homewood, Ala., plans to consolidate its billing operations with McKesson Revenue Management Solutions.

McKesson will provide Optimal’s physicians with revenue management services, including coding, charge entry, claims submission and follow-up, denial management, ongoing documentation education, compliance safeguards and business intelligence.

McKesson’s business reporting capabilities include McKesson Practice Focus. The web-based application enables managers to develop custom reports, helping organizations to identify and act on key business trends, McKesson said. The system also can assist in the review and re-negotiation of managed care contracts, and help monitor payer contract compliance.

Optimal provides radiology solutions for 77 physicians working at 14 hospitals in Florida, Georgia, South Carolina, Pennsylvania and Texas.

Lisa Fratt

Related Content

AI beats standard regression models at predicting lung cancer risk
AI reduces CT lung cancer screening workload by nearly 80%
How AI and CCTA help heart teams plan ahead before PCI
5 steps for evaluating radiology AI applications
Adaptable AI system detects subtle changes in imaging, has potential across multiple clinical settings
New algorithm models radiologists' eye movements to interpret chest X-rays

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.